Press Release on Audited Financial Results for the quarter and year March 31, 2026
GAUDIUMIVF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gaudium IVF reported strong Q4FY26 results with revenue of ₹30.35 Cr (up 12.74% YoY), EBITDA of ₹12.17 Cr (up 39.56% YoY with 40.10% margin), and PAT of ₹8.36 Cr (up 29.46% YoY). For full year FY26, revenue stood at ₹104.35 Cr, up 47.56% YoY from ₹70.72 Cr, driven by higher patient volumes at mature hubs and high clinical success rates. FY26 EBITDA grew to ₹37.70 Cr (up 31.69% YoY) while PAT reached ₹24.48 Cr (up 27.69% YoY). The company became India's first IVF chain to integrate AI-led embryology through a partnership with UK-based IVF 2.0, deploying SiD and ERICA platforms. Gaudium maintains 7 hubs and 28 spokes with a 58% clinical pregnancy success rate.
Strong financial performance with near 48% revenue growth demonstrates robust execution; however, full-year EBITDA margin compressed to 36.13% from 40.48% in FY25, which could concern margin-focused investors despite improved Q4 margins.